| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |